Showing results (551-560 of 623) with videos related to
Sort By:
Pageof 63
Family Practice|June 6, 2019
Burden of disease in children with respiratory tract infections in primary care: diary-based cohort studyM J C Schot, A R J Dekker, C H van Werkhoven, et al.Current Oncology Reports|April 10, 2024
Advances in Radionuclide Therapies for Patients with Neuro-endocrine TumorsDenise S Hoogenkamp, Linda J de Wit-van der Veen, Daphne M V Huizing, et al.The European Journal of General Practice|May 18, 2012
Patient adherence to prescribed medication instructions for dyspepsia: the DIAMOND-studyG A J Fransen, I Mesters, J W M Muris, et al.Leukemia Research|May 22, 2024
MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratioStefan G C Mestrum, B Y Vanblarcum Roanalis, Norbert C J de Wit, et al.Data in Brief|July 6, 2023
Impact of the gating strategy for Ki-67 and Bcl-2 on the determination of proliferation and anti-apoptosis data by flow cytometry in non-malignant bone marrow aspirates and aspirates from patients with myeloid malignanciesStefan G C Mestrum, Roanalis B Y Vanblarcum, Norbert C J de Wit, et al.Clinical Chemistry and Laboratory Medicine|December 22, 2016
Within-day biological variation and hour-to-hour reference change values for hematological parametersJudith M Hilderink, Lieke J J Klinkenberg, Kristin M Aakre, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 24, 2018
Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary careCharles W Helsper, Liesbeth M Van Vliet, Mary E Velthuizen, et al.Alimentary Pharmacology & Therapeutics|December 5, 2008
Psychopathology is associated with dyspeptic symptom severity in primary care patients with a new episode of dyspepsiaS Mujakovic, N J de Wit, C J van Marrewijk, et al.The European Journal of General Practice|August 15, 2019
What should selective cardiometabolic prevention programmes in European primary care look like? A consensus-based design by the SPIMEU groupNorbert Král, Anne-Karien M de Waard, François G Schellevis, et al.Plos One|November 18, 2021
Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy courseDaphne M V de Vries-Huizing, Michelle W J Versleijen, Michiel Sinaasappel, et al.Pageof 63